Morbilliform exanthem induced by imiquimod in a patient with drug-related immunosuppression

Clinical and Experimental Dermatology

Volumn 34, Issue 4, 2009, Pages 526-527

  Cavicchini, S ^a   Vezzoli, P ^a   Muratori, S ^a   Gianotti, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; PREDNISONE;

ADULT; APPLICATION SITE CRUSTING; APPLICATION SITE EROSION; APPLICATION SITE ERYTHEMA; APPLICATION SITE REACTION; BASAL CELL CARCINOMA; BLOOD CELL COUNT; BULLOUS PEMPHIGOID; CASE REPORT; DRUG ERUPTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LETTER; LYMPHOCYTIC INFILTRATION; MALE; MEASLES LIKE RASH; PATIENT SATISFACTION; PRIORITY JOURNAL; SKIN ATROPHY; SKIN BIOPSY;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; DRUG ERUPTIONS; EXANTHEMA; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS;

EID: 65649120789     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02971.x     Document Type: Letter

References (5)

1. Geisse J, Caro I, Lindholm J et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004 50 : 722 33. (Pubitemid 38580549)
2. Merk HF, Hertl M. Immunologic mechanisms of cutaneous drug reactions. Semin Cutan Med Surg 1996 15 : 228 35. (Pubitemid 27197961)
3. Fanti PA, Dika E, Vaccari S et al. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 2006 45 : 1464 5.
4. Barton JC. Angioedema associated with imiquimod. J Am Acad Dermatol 2004 51 : 477 8. (Pubitemid 39178680)
5. Benson E. Imiquimod: potential risk of an immunostimulant. Australas J Dermatol 2004 45 : 123 4. (Pubitemid 38607927)